Abstract The clinical landscape of early stage nonsmall cell lung cancer is at transformative crossroads. Driven by the widespread adoption of low‐dose computed tomography screening, the frequent detection of ground‐glass opacities, and a rising incidence among never‐smokers, the diagnostic center of gravity has shifte...
Chao-Qi Zhang, Xuan-Yu Gu, Pan-Hong Wang et al.· Ca· 1 citation
Simple Summary Distinguishing malignant from benign pleural and peritoneal effusions is essential for cancer diagnosis and treatment, but routine cytology often fails to detect malignant cells. We evaluated a DNA methylation test based on two cancer-related genes, SHOX2 and RASSF1A, in 696 patients with pleural or peri...
Ting Wang, Ting Liang, Matthew Kafarski et al.· Cancers· 0 citations
Lung cancer remains the leading cause of cancer-related mortality worldwide, with poor prognosis in advanced stage diseases. Although early diagnosis has the potential to improve patient outcomes, current diagnostic methods remain suboptimal, highlighting the need for accurate molecular biomarkers. We systematically re...
Ting Wang, Jian-Guo Zhang, Jia-Yang Wang et al.· Oncology Reviews· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
